International Eczema Council
Prev MonthPrev Month Next MonthNext Month
IEC at AAD 2024 - San Diego, CA, USA
Thursday, March 07, 2024, 2:00 PM - 5:00 PM PDT
Category: IEC Events (for everyone)

Topicals in the Pipeline: New and Emerging Therapies

At Global Education Day - AAD 2024 | March 7, 2024 | 2:00 - 5:00 PM  Pacific Time 

San Diego Convention Center, 111 W Harbor Dr., San Diego, CA 92101 | Room 30 AB

The IEC symposium will take place prior to the American Academy of Dermatology 2024 Annual Meeting (AAD) in San Diego, CA, USA. 





This symposium will explore the latest developments in the topical pipeline, helping clinicians gain critical knowledge to revolutionize their approach to AD management. Attendees of this program will come away with a clinical toolset designed to help the clinician distill a broad variety of critical topics related to novel therapeutics. Participants will also sharpen their skills to better discern which patients are best suited for topicals versus systemic treatments, ensuring a tailored and effective therapeutic plan. Additional sessions will discuss and tackle nuanced challenges in topical steroid use, providing evidence-based insights into controversies while also offering strategies for leveraging approved, non-steroidal topical therapies. Join us in this learning experience designed to elevate your practice and optimize patient outcomes.

At the conclusion of this symposium, participants will be able to:

  1. Identify gaps in the current topical therapeutic landscape for AD
  2. Evaluate efficacy and safety of new and emerging topical therapies for AD
  3. Identify AD patients appropriate for topical, systemic therapies, or combined therapies.



April Armstrong, MD, MPH
Los Angeles, CA

IEC Councilor


Alan Irvine, MD DSc
Dublin, Ireland

IEC President-Elect



2 – 2:15 PM | Welcome and Introductions from the IEC; Introduction to IEC’s New Incoming President
Robert Bissonnette, MD FRCPC MSc | Montréal, QC, Canada
Alan Irvine, MD DSc | Dublin, Ireland

2:15 – 2:35 PM |  Chris, Jack, and You: Clinical pearls on the use of approved non-steroidal topical therapies, including crisaborole and ruxolitinib in AD
Linda Stein Gold, MD | Detroit, MI   

2:35-2:55 PM | Friend or foe: Controversies in topical steroid use for AD
Peter A. Lio, MD | Chicago, IL 

2:55-3:05 PM | Q & A with speakers

3:05-3:30 PM | Refreshment Break

3:30 – 3:50 PM | What’s topical in the topical pipeline? An evaluation of tapinarof and roflumilast in AD
April Armstrong, MD MPH | IEC Councilor | Los Angeles, CA

3:50 – 4:10 PM | Making sense of it all: Distilling the complexities of therapeutics (JAKi, AhR, PDE4s) and identifying their therapeutic niche
Benjamin D. Ehst, MD PhD | Portland, OR

4:10 – 4:25 PM | Q & A with speakers

4:25 – 4:45 PM | Patients Appropriate for Topicals vs. Systemics & Barriers to topicals
Robert Bissonnette, MD FRCPC MSc | IEC President | Montréal, QC, Canada

4:45-5 PM | Wrap-Up, Closing Remarks & Adjourn
Alan Irvine, MD DSc | incoming IEC President | Dublin, Ireland


This educational symposium presented by the IEC is offered at no cost to attendees.



IEC will comply with AAD and local mandates at the time of the in-person meeting.  Visit the AAD's website for more information.